Collplant Holdings (CLGN)
NASDAQ:CLGN

Collplant Holdings (CLGN) Stock Price & Analysis

132 Followers

CLGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.27 - $13.97
Previous Close$7.37
Volume13.04K
Average Volume (3M)8.11K
Market Cap
$82.44M
Enterprise Value$55.70M
Total Cash (Recent Filing)$29.65M
Total Debt (Recent Filing)$2.91M
Price to Earnings (P/E)-4.8
Beta0.69
Sep 22, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.52
Shares Outstanding11,190,000
10 Day Avg. Volume8,933
30 Day Avg. Volume8,113
Standard Deviation0.22
R-Squared0.00424
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)2.72
Price to Sales (P/S)275.82
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue231.13
Enterprise Value/Gross Profit-551.51
Enterprise Value/Ebitda-4.79
Forecast
Price Target Upside46.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

CLGN FAQ

What was Collplant Holdings’s price range in the past 12 months?
Collplant Holdings lowest stock price was $4.27 and its highest was $13.97 in the past 12 months.
    What is Collplant Holdings’s market cap?
    Currently, no data Available
    When is Collplant Holdings’s upcoming earnings report date?
    Collplant Holdings’s upcoming earnings report date is Sep 22, 2023 which is in 108 days.
      How were Collplant Holdings’s earnings last quarter?
      Collplant Holdings released its earnings results on May 24, 2023. The company reported -$0.33 earnings per share for the quarter, missing the consensus estimate of -$0.29 by -$0.04.
        Is Collplant Holdings overvalued?
        According to Wall Street analysts Collplant Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Collplant Holdings pay dividends?
          Collplant Holdings does not currently pay dividends.
          What is Collplant Holdings’s EPS estimate?
          Collplant Holdings’s EPS estimate is -$0.34.
            How many shares outstanding does Collplant Holdings have?
            Collplant Holdings has 11,186,481 shares outstanding.
              What happened to Collplant Holdings’s price movement after its last earnings report?
              Collplant Holdings reported an EPS of -$0.33 in its last earnings report, missing expectations of -$0.29. Following the earnings report the stock price went up 5.694%.
                Which hedge fund is a major shareholder of Collplant Holdings?
                Among the largest hedge funds holding Collplant Holdings’s share is ARK Investment Management LLC. It holds Collplant Holdings’s shares valued at N/A.

                  ---

                  Collplant Holdings Stock Smart Score

                  The Collplant Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Collplant Holdings

                  CollPlant Biotechnologies Ltd. is a regenerative medicine company. It engages in the research, development, manufacture and marketing of medical products for tissue repair, initially for orthobiologics and advanced wound care markets. The company's products include VergenixSTR, VergenixFG, CollPlant Surgical Matrix. Collplant Holdings was founded by in June 2004 and is headquartered in Ness-Ziona, Israel.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Intellia Therapeutics
                  Crispr Therapeutics AG
                  Editas Medicine
                  Bluebird Bio

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis